- Home
- SRZN vs STHO Comparison
SRZN vs STHO Comparison
Compare SRZN & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- STHO
- Stock Information
- Founded
- SRZN 2015
- STHO N/A
- Country
- SRZN United States
- STHO United States
- Employees
- SRZN N/A
- STHO N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- STHO Real Estate
- Sector
- SRZN Health Care
- STHO Real Estate
- Exchange
- SRZN Nasdaq
- STHO Nasdaq
- Market Cap
- SRZN 117.8M
- STHO 112.7M
- IPO Year
- SRZN N/A
- STHO N/A
- Fundamental
- Price
- SRZN $13.23
- STHO $7.63
- Analyst Decision
- SRZN Strong Buy
- STHO
- Analyst Count
- SRZN 2
- STHO 0
- Target Price
- SRZN $38.50
- STHO N/A
- AVG Volume (30 Days)
- SRZN 92.5K
- STHO 42.3K
- Earning Date
- SRZN 11-07-2025
- STHO 11-07-2025
- Dividend Yield
- SRZN N/A
- STHO N/A
- EPS Growth
- SRZN N/A
- STHO N/A
- EPS
- SRZN N/A
- STHO N/A
- Revenue
- SRZN $3,604,000.00
- STHO $117,547,000.00
- Revenue This Year
- SRZN N/A
- STHO N/A
- Revenue Next Year
- SRZN N/A
- STHO N/A
- P/E Ratio
- SRZN N/A
- STHO N/A
- Revenue Growth
- SRZN N/A
- STHO N/A
- 52 Week Low
- SRZN $5.90
- STHO $6.06
- 52 Week High
- SRZN $18.17
- STHO $11.48
- Technical
- Relative Strength Index (RSI)
- SRZN 51.18
- STHO 51.17
- Support Level
- SRZN $12.12
- STHO $7.25
- Resistance Level
- SRZN $14.18
- STHO $7.67
- Average True Range (ATR)
- SRZN 0.75
- STHO 0.30
- MACD
- SRZN 0.06
- STHO 0.03
- Stochastic Oscillator
- SRZN 61.92
- STHO 57.78
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.